Abstract:Non-technical summary Activation of the sympathetic nervous system hastens the rate of progression and severity of chronic heart failure (CHF). Chemically sensitive nerves in the carotid body (CB) that stimulate sympathetic nerve activity become overly active in CHF and contribute to this phenomenon. The stimulus for activation of these CB chemoreceptors is not known. Blood supply to tissues is impaired due to the failing heart. In this study we tested whether a chronic reduction in blood flow to the CB may contribute to altered CB chemoreceptor function. The results show that changes that occur in CB chemoreceptor function during CHF are identical to those that occur if blood flow is simply reduced to the CB for several weeks. The results suggest that chronic impairment of blood flow may be the key step in the pathophysiological events that cause sympathetic nervous system activation in heart failure. Abstract Peripheral chemoreflex sensitivity is potentiated in clinical and experimental chronic heart failure (CHF). Blood supply to tissues is inevitably reduced in CHF. However, it remains poorly understood whether the reduced blood flow is the cause of increased peripheral chemoreflex sensitivity in CHF. This work highlights the effect of chronically reduced blood flow to the carotid body (CB) on peripheral chemoreflex function in rabbits. In pacing-induced CHF rabbits, blood flow in the carotid artery was reduced by 36.4 +/- 5.2% after 3 weeks of pacing. For comparison, a similar level of blood flow reduction was induced by carotid artery occlusion (CAO) over a similar 3 week time course without pacing. CB blood supply was reduced by similar levels in both CHF and CAO rabbits as measured with fluorescent microspheres. Compared with sham rabbits, CAO enhanced peripheral chemoreflex sensitivity in vivo, increased CB chemoreceptor activity in an isolated CB preparation and decreased outward potassium current (I-k) in CB glomus cells to levels similar to those that were observed in CHF rabbits. In CAO CB compared to sham, neural nitric oxide (NO) synthase (nNOS) expression and NO levels were suppressed, and angiotensin II (Ang II) type 1 receptor (AT(1)-R) protein expression and Ang II concentration were elevated; these changes were similar to those seen in the CB from CHF rabbits. A NO donor and AT(1)-R antagonist reversed CAO-enhanced chemoreflex sensitivity. These results suggest that a reduction of blood flow to the CB is involved in the augmentation of peripheral chemoreflex sensitivity in CHF.

Role of blood flow in carotid body chemoreflex function in heart failure.

Carotid body function in heart failure

Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits.

Mechanisms of carotid body chemoreflex dysfunction during heart failure

Role of CuZn Superoxide Dismutase on Carotid Body Function in Heart Failure Rabbits.

Cardiac Sympathetic Afferent Stimulation Augments The Arterial Chemoreceptor Reflex In Anesthetized Rats

Is Carotid Body Denervation the Silver Bullet for Heart Failure?

Exercise Training Improves Peripheral Chemoreflex Function In Heart Failure Rabbits

Downregulation of Carbon Monoxide As Well As Nitric Oxide Contributes to Peripheral Chemoreflex Hypersensitivity in Heart Failure Rabbits.

Central role of carotid body chemoreceptors in disordered breathing and cardiorenal dysfunction in chronic heart failure

Enhanced Peripheral Chemoreflex Function in Conscious Rats with Ligation‐induced Heart Failure

Enhanced sensitivity of Kv channels to hypoxia in the rabbit carotid body in heart failure: role of angiotensin II.

Exercise Training Normalizes Enhanced Peripheral Chemoreflex Function in Chronic Heart Failure Rabbits

NADPH Oxidase-Derived Superoxide Anion Mediates Angiotensin II-enhanced Carotid Body Chemoreceptor Sensitivity in Heart Failure Rabbits.

Interaction between cardiac sympathetic afferent reflex and chemoreflex is mediated by the NTS AT1 receptors in heart failure.

Augmented input from cardiac sympathetic afferents inhibits the baroreflex in heart failure

Attenuated Outward Potassium Currents in Carotid Body Glomus Cells of Heart Failure Rabbit: Involvement of Nitric Oxide

Carotid body chemoreceptors, sympathetic neural activation, and cardiometabolic disease

NO modulation of carotid body chemoreception in health and disease

Cardiac Sympathetic Afferent Stimulation Inhibits the Arterial Baroreflex in He Art Failure at the Level of the Nucleus Tractus Solitarius by an Angiotensin Ii Mechanism

Abnormal Baroreflex Function is Dissociated from Central Angiotensin Ii Receptor Expression in Chronic Heart Failure